Abstract | OBJECTIVE: DESIGN: Prospective randomized double-masked clinical trial. PARTICIPANTS: METHODS: Patients were randomly assigned to an immediately postoperative drop of either timolol maleate 0.5% or no treatment. Intraocular pressure was measured preoperatively and 4, 8, and 24 hours and 1 week later. MAIN OUTCOME MEASURES: Intraocular pressure measurements. RESULTS: The changes in postoperative IOP over time differed significantly between glaucoma, exfoliation syndrome, and normal (P = 0.005). Intraocular pressure was significantly lower in the normal group (n = 25) than in both the glaucoma (n = 18) and exfoliation syndrome (n = 19) groups (P<0.001). With 1 drop of prophylactic timolol maleate 0.5% at completion of surgery, the normal group (n = 25) again had IOP significantly lower than those of the glaucoma (n = 15) and exfoliation syndrome (n = 20) groups (P<0.001). Treatment with timolol maleate 0.5% significantly changed postoperative IOP over time in the glaucomatous eyes (P = 0.003), but it made no difference in the exfoliation syndrome (P = 0.4) or normal (P = 0.5) eyes. Intraocular pressure > 25 mmHg did not occur among normal eyes. Intraocular pressure > 25 mmHg and > 30 mmHg occurred in 10 (55%) and 5 (28%) glaucoma patients, respectively, and 5 (27%) and 2 (11%) exfoliation syndrome patients, respectively. Timolol maleate 0.5% eliminated IOP spikes > 30 mmHg and reduced the frequency of IOP > 25 mmHg in both groups to 14% in the glaucoma group and 5% in the exfoliation syndrome group. Most IOP elevation occurred at 4 hours postoperatively. The mean IOP was <20 mmHg in all groups 1 day postoperatively. CONCLUSIONS: Medically well-controlled glaucoma patients and patients with exfoliation syndrome may experience IOP elevation shortly after cataract surgery. Instillation of timolol maleate 0.5% at the end of the procedure in this series eliminated IOP > 30 mmHg, but IOP elevation below that level can still occur.
|
Authors | Hani Levkovitch-Verbin, Zohar Habot-Wilner, Nirit Burla, Shlomo Melamed, Modi Goldenfeld, Shai M Bar-Sela, Dan Sachs |
Journal | Ophthalmology
(Ophthalmology)
Vol. 115
Issue 1
Pg. 104-8
(Jan 2008)
ISSN: 1549-4713 [Electronic] United States |
PMID | 17561259
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antihypertensive Agents
- Ophthalmic Solutions
- Timolol
|
Topics |
- Aged
- Antihypertensive Agents
(administration & dosage)
- Circadian Rhythm
- Double-Blind Method
- Exfoliation Syndrome
(complications)
- Female
- Glaucoma, Open-Angle
(complications)
- Humans
- Intraocular Pressure
- Male
- Ocular Hypertension
(drug therapy, etiology)
- Ophthalmic Solutions
(administration & dosage)
- Phacoemulsification
- Postoperative Complications
- Prospective Studies
- Timolol
(administration & dosage)
- Tonometry, Ocular
|